Targets of drugs are generally, and targets of drugs having side effects are specifically good spreaders of human interactome perturbations

Perez-Lopez, Á. R. and Szalay, K. Z. and Türei, D. and Módos, Dezső and Földvári-Nagy Lászlóné Lenti, Katalin and Korcsmáros, Tamás and Csermely, Péter (2015) Targets of drugs are generally, and targets of drugs having side effects are specifically good spreaders of human interactome perturbations. SCIENTIFIC REPORTS, 5. ISSN 2045-2322

Preview

Text 1504.00272.pdf Available under License Creative Commons Attribution. Download (1MB) | Preview

Abstract

Network-based methods are playing an increasingly important role in drug design. Our main question in this paper was whether the efficiency of drug target proteins to spread perturbations in the human interactome is larger if the binding drugs have side effects, as compared to those which have no reported side effects. Our results showed that in general, drug targets were better spreaders of perturbations than non-target proteins, and in particular, targets of drugs with side effects were also better spreaders of perturbations than targets of drugs having no reported side effects in human protein-protein interaction networks. Colorectal cancer-related proteins were good spreaders and had a high centrality, while type 2 diabetes-related proteins showed an average spreading efficiency and had an average centrality in the human interactome. Moreover, the interactome-distance between drug targets and disease-related proteins was higher in diabetes than in colorectal cancer. Our results may help a better understanding of the network position and dynamics of drug targets and disease-related proteins, and may contribute to develop additional, network-based tests to increase the potential safety of drug candidates.

Actions (login required)

Edit Item